{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:35:49Z","timestamp":1790375749376,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016206","name":"Clinical and Translational Science Institute, University of California, Los Angeles","doi-asserted-by":"publisher","award":["UL1TR001881"],"award-info":[{"award-number":["UL1TR001881"]}],"id":[{"id":"10.13039\/100016206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["20174717"],"award-info":[{"award-number":["20174717"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["\/ NHLBI F31 HL134313"],"award-info":[{"award-number":["\/ NHLBI F31 HL134313"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011075","name":"David Geffen School of Medicine, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T22:23:07Z","timestamp":1587162187000},"page":"999-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Creating New \u03b2-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences"],"prefix":"10.1016","volume":"17","author":[{"given":"Richard A.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mildred J.","family":"Unti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul George","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Lathrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bamidele","family":"Aleshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantha","family":"Senadheera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger P.","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.04.006_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib2","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.04.006_bib3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2020.04.006_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib6","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.04.006_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.04.006_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib10","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1126\/science.1065806","article-title":"Correction of sickle cell disease in transgenic mouse models by gene therapy","volume":"294","author":"Pawliuk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.04.006_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib12","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.04.006_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35017565","article-title":"Therapeutic haemoglobin synthesis in \u03b2-thalassaemic mice expressing lentivirus-encoded human \u03b2-globin","volume":"406","author":"May","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.04.006_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.omtm.2018.07.012","article-title":"An optimized lentiviral vector efficiently corrects the human sickle cell disease phenotype","volume":"10","author":"Weber","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.04.006_bib15","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/MCB.21.9.2969-2980.2001","article-title":"Sequences flanking hypersensitive sites of the beta-globin locus control region are required for synergistic enhancement","volume":"21","author":"Molete","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.04.006_bib16","doi-asserted-by":"crossref","first-page":"16077","DOI":"10.1038\/mtm.2016.77","article-title":"The identification of hematopoietic-specific regulatory elements for WASp gene expression","volume":"14","author":"Zhan","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.04.006_bib17","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2007-08-108647","article-title":"Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in \u03b2-thalassemic mice","volume":"110","author":"Lisowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.04.006_bib18","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1073\/pnas.92.15.6728","article-title":"Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene","volume":"92","author":"Sadelain","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.04.006_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/hgtb.2012.073","article-title":"Restricted transgene expression in the brain with cell-type specific neuronal promoters","volume":"23","author":"Delzor","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.04.006_bib20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0092-8674(87)90584-8","article-title":"Position-independent, high-level expression of the human beta-globin gene in transgenic mice","volume":"51","author":"Grosveld","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.04.006_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1101\/gad.3.3.314","article-title":"A single erythroid-specific DNase I super-hypersensitive site activates high levels of human \u03b2-globin gene expression in transgenic mice","volume":"3","author":"Ryan","year":"1989","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2020.04.006_bib22","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1073\/pnas.93.13.6605","article-title":"Effect of deletion of 5\u2032HS3 or 5\u2032HS2 of the human beta-globin locus control region on the developmental regulation of globin gene expression in beta-globin locus yeast artificial chromosome transgenic mice","volume":"93","author":"Peterson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.04.006_bib23","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1128\/MCB.23.24.8946-8952.2003","article-title":"Human \u03b2-globin locus control region HS5 contains CTCF-and developmental stage-dependent enhancer-blocking activity in erythroid cells","volume":"23","author":"Tanimoto","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2020.04.006_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bcmd.2007.02.006","article-title":"Deletion of the human \u03b2-globin LCR 5\u2032HS4 or 5\u2032HS1 differentially affects \u03b2-like globin gene expression in \u03b2-YAC transgenic mice","volume":"39","author":"Fedosyuk","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.omtm.2020.04.006_bib25","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1093\/nar\/gks900","article-title":"LCR 5\u2032 hypersensitive site specificity for globin gene activation within the active chromatin hub","volume":"40","author":"Peterson","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/j.1460-2075.1990.tb08100.x","article-title":"Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression","volume":"9","author":"Collis","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.omtm.2020.04.006_bib27","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/nar\/18.12.3503","article-title":"DNasel hypersensitive sites 1, 2 and 3 of the human \u03b2-globin dominant control region direct position-independent expression","volume":"18","author":"Fraser","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1101\/gad.7.1.106","article-title":"Each hypersensitive site of the human \u03b2-globin locus control region confers a different developmental pattern of expression on the globin genes","volume":"7","author":"Fraser","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2020.04.006_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.04.006_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nbt.3754","article-title":"Genome-wide mapping of autonomous promoter activity in human cells","volume":"35","author":"van Arensbergen","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2020.04.006_bib31","first-page":"e16","article-title":"A genome-integrated massively parallel reporter assay reveals DNA sequence determinants of cis-regulatory activity in neural cells","volume":"45","author":"Maricque","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1101\/gr.212092.116","article-title":"A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity","volume":"27","author":"Inoue","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib33","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gr.173518.114","article-title":"High-throughput functional testing of ENCODE segmentation predictions","volume":"24","author":"Kwasnieski","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib34","article-title":"Massively parallel characterization of regulatory dynamics during neural induction","author":"Inoue","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2020.04.006_bib35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1101\/gr.169243.113","article-title":"Dissection of thousands of cell type-specific enhancers identifies dinucleotide repeat motifs as general enhancer features","volume":"24","author":"Y\u00e1\u00f1ez-Cuna","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ng.2713","article-title":"Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model","volume":"45","author":"Smith","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.04.006_bib37","doi-asserted-by":"crossref","first-page":"11952","DOI":"10.1073\/pnas.1307449110","article-title":"Massively parallel in\u00a0vivo enhancer assay reveals that highly local features determine the cis-regulatory function of ChIP-seq peaks","volume":"110","author":"White","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.04.006_bib38","doi-asserted-by":"crossref","first-page":"E1291","DOI":"10.1073\/pnas.1621150114","article-title":"Systematic dissection of genomic features determining transcription factor binding and enhancer function","volume":"114","author":"Grossman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.04.006_bib39","article-title":"Meta-analysis of massive parallel reporter assay enables functional regulatory elements prediction","author":"Kreimer","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2020.04.006_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt.2136","article-title":"Massively parallel functional dissection of mammalian enhancers in\u00a0vivo","volume":"30","author":"Patwardhan","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2020.04.006_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bcmd.2017.08.001","article-title":"Evolution of hemoglobin loci and their regulatory elements","volume":"70","author":"Philipsen","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.omtm.2020.04.006_bib42","doi-asserted-by":"crossref","first-page":"11871","DOI":"10.1074\/jbc.271.20.11871","article-title":"Role of DNA sequences outside the cores of DNase hypersensitive sites (HSs) in functions of the \u03b2-globin locus control region. Domain opening and synergism between HS2 and HS3","volume":"271","author":"Jackson","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.04.006_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0092-8674(00)80686-8","article-title":"Looping, linking, and chromatin activity: new insights into beta-globin locus regulation","volume":"100","author":"Engel","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2020.04.006_bib44","series-title":"The Molecular Basis of Blood Diseases","author":"Stamatoyannopoulos","year":"1994"},{"key":"10.1016\/j.omtm.2020.04.006_bib45","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1101\/gr.3642605","article-title":"Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences","volume":"15","author":"King","year":"2005","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib46","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1089\/hum.2018.061","article-title":"Gene therapy for sickle cell disease: a lentiviral vector comparison study","volume":"29","author":"Urbinati","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.04.006_bib47","doi-asserted-by":"crossref","first-page":"27518","DOI":"10.1074\/jbc.M402578200","article-title":"A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin","volume":"279","author":"Levasseur","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.04.006_bib48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/0022-1317-82-5-1013","article-title":"Analysis of the aphthovirus 2A\/2B polyprotein \u201ccleavage\u201d mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal \u201cskip\u201d","volume":"82","author":"Donnelly","year":"2001","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2020.04.006_bib49","doi-asserted-by":"crossref","first-page":"e59890","DOI":"10.1371\/journal.pone.0059890","article-title":"Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells","volume":"8","author":"Kurita","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.04.006_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.celrep.2016.08.083","article-title":"Reversible regulation of promoter and enhancer histone landscape by DNA methylation in mouse embryonic stem cells","volume":"17","author":"King","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2020.04.006_bib51","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1101\/gr.135707.111","article-title":"Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq","volume":"22","author":"Tallack","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbagrm.2014.12.010","article-title":"KLF1 stabilizes GATA-1 and TAL1 occupancy in the human \u03b2-globin locus","volume":"1849","author":"Kang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2020.04.006_bib53","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/bioinformatics\/btr064","article-title":"FIMO: scanning for occurrences of a given motif","volume":"27","author":"Grant","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2020.04.006_bib54","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/104303401753153947","article-title":"Systematic determination of the packaging limit of lentiviral vectors","volume":"12","author":"Kumar","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.04.006_bib55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2019.09.020","article-title":"Improved titer and gene transfer by lentiviral vectors using novel, small \u03b2-globin locus control region elements","volume":"28","author":"Morgan","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.04.006_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13104-016-2118-z","article-title":"Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters","volume":"9","author":"Cant\u00e9-Barrett","year":"2016","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.omtm.2020.04.006_bib57","first-page":"8","article-title":"What are super-enhancers? Nat","volume":"47","author":"Pott","year":"2015","journal-title":"Genet"},{"key":"10.1016\/j.omtm.2020.04.006_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrg3458","article-title":"Enhancers: five essential questions","volume":"14","author":"Pennacchio","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2020.04.006_bib59","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1182\/blood-2003-04-1251","article-title":"Correction of a mouse model of sickle cell disease: lentiviral\/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells","volume":"102","author":"Levasseur","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.04.006_bib60","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic stem cell gene therapy: progress and lessons learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2020.04.006_bib61","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/nar\/gkw278","article-title":"Jointly characterizing epigenetic dynamics across multiple human cell types","volume":"44","author":"Zhang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2020.04.006_bib62","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.omtm.2019.03.005","article-title":"PGE2 and poloxamer synperonic F108 enhance transduction of human HSPCs with a \u03b2-globin lentiviral vector","volume":"13","author":"Masiuk","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.04.006_bib63","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/humu.23797","article-title":"Integration of multiple epigenomic marks improves prediction of variant impact in saturation mutagenesis reporter assay","volume":"40","author":"Shigaki","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2020.04.006_bib64","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.04.006_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2011.06.019","article-title":"Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration","volume":"177","author":"Cooper","year":"2011","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2020.04.006_bib66","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1172\/JCI67930","article-title":"\u03b2-globin gene transfer to human bone marrow for sickle cell disease","volume":"123","author":"Romero","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.04.006_bib67","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jcyt.2017.06.002","article-title":"Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease","volume":"19","author":"Urbinati","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omtm.2020.04.006_bib68","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal. Chem."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:52:29Z","timestamp":1778867549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120300668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":68,"alternative-id":["S2329050120300668"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.04.006","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creating New \u03b2-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}